Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
68 hedge funds and large institutions have $10.6M invested in Mural Oncology in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 15 closing their positions.
278% more call options, than puts
Call options by funds: $185K | Put options by funds: $49K
6.71% less ownership
Funds ownership: 55.44% → 48.73% (-6.7%)
11% less funds holding
Funds holding: 76 → 68 (-8)
38% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 24
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
65% less capital invested
Capital invested by funds: $30.5M → $10.6M (-$19.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$583K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$381K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$316K |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$266K |
| 5 |
Two Sigma Advisers
New York
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Solas Capital Management
Darien,
Connecticut
|
-$1.39M |
| 2 |
Renaissance Technologies
New York
|
-$768K |
| 3 |
Squarepoint
New York
|
-$565K |
| 4 |
AGM
Alpine Global Management
New York
|
-$521K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$358K |
MURA Hedge Fund Activity: Q1 2025 in Review
68 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q1 2025, worth a combined $10.6M — down 65% from $30.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of MURA and 8 opened new positions — a net loss of 7 holders — while 24 trimmed existing stakes and 15 added.
The largest buyer was Royal Bank of Canada, adding an estimated $583K. The largest seller was Solas Capital Management, cutting an estimated $1.39M.
- 68 institutional investors held Mural Oncology (MURA) as of Q1 2025, down from 76 in Q4 2024.
- Funds reported $10.6M of Mural Oncology stock for Q1 2025, down 65% quarter-over-quarter.
- 8 funds opened new Mural Oncology positions in Q1 2025 and 15 closed out, a net change of -7 holders.
- The largest Mural Oncology buyer in Q1 2025 was Royal Bank of Canada, an estimated $583K added.
- The largest Mural Oncology seller in Q1 2025 was Solas Capital Management, an estimated $1.39M sold.
Based on aggregated 13F filings for Q1 2025.